Unlocking the Secret of Global Health Victories

Unlocking the Secret of Global Health Victories

Tuesday, November 12, 2013

Japan Society

Presented By

Presented by The Global Health Innovative Technology Fund, Japan Society, and the New York Academy of Sciences

 

The Global Health Innovative Technology Fund (GHIT Fund) is a first-ever initiative to bring together the resources and know-how of Japan's public and private sectors to fund and support global efforts to address diseases of the poorest of the poor outside of Japan.

The GHIT Fund, along with the New York Academy of Sciences and Japan Society, are hosting a panel – comprised of preeminent global health experts – to discuss recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.

Panelists will provide their unique perspectives on:

  • How do these partnerships find success in the face of seemingly insurmountable challenges?
  • What have we learned from pass successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
  • What are the opportunities for the next big solutions?
  • Who is missing from the table in the efforts to push back against HIV, TB, malaria, and neglected tropical diseases?
  • Why should those outside the global health and NGO worlds join this effort?

The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.

This is a free event open to the public, but you must pre-register for the program. Seating is available on a first come, first served basis.

Speaker

B.T. Slingsby, MD, PhD, MPH

Chief Executive Officer & Executive Director, GHIT Fund

Panelists

Kiyoshi Kurokawa, MD

Chair of the Board of GHIT Fund
Academic Fellow, National Graduate Institute for Policy Studies
Chairman, Health and Global Policy Institute

Peter Piot, MD, PhD

Director, London School of Hygiene & Tropical Medicine
Board Advisor, GHIT Fund

Mel Spigelman, MD

President & Chief Executive Officer, Global Alliance for TB Drug Development

Ann M. Veneman, JD

Former Executive Director, UNICEF
Board Advisor, GHIT Fund

Moderator

Ko-Yung Tung

Senior Partner, Morrison & Foerster LLP


Presented by

  • The Global Health Innovative Technology Fund
  • Japan Society
  • NYAS

Agenda

* Presentation titles and times are subject to change.


Tuesday, November 12, 2013

6:00 PM

Registration

6:30 PM

Opening Remarks
B.T. Slingsby, MD, PhD, MPH, CEO & Executive Director, GHIT Fund

Panel Discussion
Moderator: Ko-Yung Tung, JD, Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor

On Engaging New Partners: Why New Players are Coming to the Global Health Table
Kiyoshi Kurokawa, MD, Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute

On Responding to a Global Health Crisis: Lessons from AIDS
Peter Piot, MD, PhD, Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member

On Developing New Tools for Old Threats: Identifying Promising Candidates and Carrying them Across the Finish Line
Mel Spigelman, MD, President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee

On Reaching Those in Need: Disseminating the Latest Breakthroughs
Ann M. Veneman, JD, Former Executive Director of UNICEF; GHIT Fund Board Member

8:00 PM

Reception

8:30 PM

Adjourn

Speakers

Featuring

Kiyoshi Kurokawa, MD

Chair of the Board of GHIT Fund
Academic Fellow, National Graduate Institute for Policy Studies
Chairman, Health and Global Policy Institute

Dr. Kurokawa is a graduate of University of Tokyo Faculty of Medicine. He was a professor of medicine at the School of Medicine of UCLA (1979-84), the University of Tokyo (1989-96), and was the Dean of Tokai University School of Medicine (1996-2002). He has served as the President of Science Council of Japan from 2003 to 2006 and the Science Advisor to the Prime Minister from 2006 to 2008. He serves as an executive member of many national and international professional societies, and as a World Health Organization Commissioner from 2005 to 2009. You can read more about Dr. Kurokawa at www.kiyoshikurokawa.com/en.

Peter Piot, MD, PhD

Director, London School of Hygiene & Tropical Medicine
Former Executive Director of UNAIDS
GHIT Fund Board Member

Peter Piot, MD, PhD is the Director of the London School of Hygiene & Tropical Medicine, and Professor of Global Health. In 2009-2010 he was the Director of the Institute for Global Health at Imperial College, London. He was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, and was an Associate Director of the Global Programme on AIDS of the World Health Organization. Dr. Piot co-discovered the Ebola virus in Zaire in 1976, and led research on AIDS, women’s health, and public health in Africa. He was knighted as a baron in 1995 and has published over 500 scientific articles and 16 books.

B.T. Slingsby, MD, PhD, MPH

Executive Director & Chief Executive Officer, GHIT Fund

Dr. Slingsby is CEO of the Global Health Innovative Technology Fund. Before his position at GHIT Fund, he was involved in the founding of for-profit and non-profit entities in the US and Japan and from 2010 – May 2013 was responsible for global access strategies for Eisai Co. & Ltd. Dr. Slingsby graduated from Brown University, earned his Masters and Doctorate from Kyoto University, The University of Tokyo, and received his Medical Doctorate from The George Washington University.

Mel Spigelman, MD

President and CEO, Global Alliance for TB Drug Development (TB Alliance)
GHIT Fund Grantee

Dr. Spigelman is the President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance). Prior to being appointed President and CEO in 2009, Dr. Spigelman served for five and a half years as the Director of Research and Development at the TB Alliance. A highly regarded expert in domestic and international drug research and development, Dr. Spigelman previously spent a decade as Vice President of R&D overseeing all research and development at Knoll Pharmaceuticals (a division of BASF Pharma). Dr. Spigelman holds board certifications from the American Board of Internal Medicine, the American Board's Subspecialty Board of Medical Oncology, and the American Board of Preventive Medicine and was the recipient of the American Cancer Society Clinical Oncology Career Development Award (1985-1988). He served on the full time faculty at the Mount Sinai Medical Center in NYC upon completing his sub-specialty fellowships. Presently, Dr. Spigelman serves on the Coordinating Board of the Stop TB Partnership, is co-chair of the Working Group on New Drugs of the Stop TB Partnership, and is a member of the Governing Board of the Tres Cantos Open Lab, GlaxoSmithKline.

Ann M. Veneman, JD

Former Executive Director of UNICEF
GHIT Fund Board Member

Ann M. Veneman has a distinguished career in public service, including serving as Executive Director of the United Nations Children’s Fund (UNICEF) from 2005 to 2010 and as the United States Secretary of Agriculture from 2001 to 2005. Ms. Veneman graduated from the University of California, Davis, and received a master’s degree in public policy from the University of California, Berkeley, and a Juris Doctor degree from the University of California, Hastings College of the Law. In 2009 she was named to the Forbes 100 Most Powerful Women list.

Moderator

Ko-Yung Tung, JD

Senior Counselor, Morrison & Foerster
GHIT Fund Board Advisor

Mr. Ko-Yung Tung is an international lawyer with Morrison & Foerster, with extensive experience in both the public and private sectors. He has served as Senior Vice President and General Counsel of the World Bank. During his tenure there, he was instrumental in establishing the Global Fund for AIDS, Tuberculosis and Malaria. He is a Visiting Lecturer at Law at Yale Law School where he teaches a course on "Globalization, Development, Poverty and the Law". He received his undergraduate degree in physics from Harvard University and his law degree from Harvard Law School.

Sponsors

Presented by

  • The Global Health Innovative Technology Fund
  • Japan Society
  • NYAS

Travel & Lodging

Event Location

Japan Society
333 East 47th Street
New York, NY 10017
www.japansociety.org

Nearby Hotels

Recommended Partner Hotel
Club Quarters, Rockefeller Center
25 West 51st Street (Off 5th Ave)
New York, NY 10019

The New York Academy of Sciences is a member of the Club Quarters network, which offers significant savings on hotel reservations to member organizations. There are many locations throughout New York City - the Rockefeller Center location is a 20-minute commute from the Event Venue.

Use Club Quarters Reservation Password NYAS to reserve your discounted accommodations online.